Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model | 1 |
Aylık toplam ziyaret
| views | |
|---|---|
| Kasım 2025 | 0 |
| Aralık 2025 | 0 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 0 |
| Nisan 2026 | 1 |
| Mayıs 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Pharmacology Res Perspec - 2024 - Göksu - Cromolyn sodium and masitinib combination inhibits fibroblast‐myofibroblast.pdf | 7 |
